Home / News & Insights / Blog / DMH Stallard leads on £24m pharma acquisition

DMH Stallard leads on £24m pharma acquisition

02 Aug 2019

Top 100 law firm DMH Stallard has completed the sale of Durbin PLC (UK) and Durbin Inc (US) to healthcare services company Uniphar.
Durbin is a worldwide sourcing and distribution pharmaceutical platform with business in the UK and the US, supplying more than 160 countries.
Dublin-based Pharma business Uniphar offers global markets a highly developed e-commerce platform and patient management system.
Financing became conditional on a public float by Uniphar in Ireland, which successfully raised €135 million, allowing the Durbin sale to complete on 31st July 2019.
The £24 million deal will see the founder of Durbin, Leslie Morgan, take up a non- executive role.
Jonathan Grant, Partner at DMH Stallard, led the team advising Durbin. He said:  “Uniphar has been a sourcing partner for Durbin since 2011.  The clear synergies between Durbin and Uniphar made this a compelling deal for both businesses.”
“I was delighted to work with Leslie and his family and assist in closing the deal as smoothly as possible.”
Capnua and William Fry led for Uniphar, with DMH Stallard handling legal and all deal negotiations for Durbin.
Durbin decided not to appoint corporate finance advisers, having agreed deal terms with Uniphar directly.

Further reading

  • Brighton Office

    1 Jubilee Street


    East Sussex

    BN1 1GE

  • Crawley Office

    Griffin House

    135 High Street


    West Sussex

    RH10 1DQ

  • Guildford Office

    Wonersh House

    The Guildway

    Old Portsmouth Road



    GU3 1LR

  • Horsham Office

    Ridgeland House

    15 Carfax


    West Sussex

    RH12 1DY

  • London Office

    6 New Street Square

    New Fetter Lane


    EC4A 3BF

  • Get in touch